Đang chuẩn bị liên kết để tải về tài liệu:
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Lymph-node (LN) metastasis is an important prognostic factor in resected pancreatic cancer. In this study, the prognostic value of American Joint Committee on Cancer (AJCC) 8th edition N stage, lymph-node ratio (LNR), and log odds of positive lymph nodes (LODDS) in resected pancreatic cancer was investigated. | Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

TÀI LIỆU LIÊN QUAN

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage

The lymph node status as a prognostic factor in colon cancer: Comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems

Lymph node ratio as a predictor for minor salivary gland cancer in head and neck

Clinical significance of neutrophil-tolymphocyte ratio as a predictor of lymph node metastasis in gastric cancer

Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: A SEER population-based study

Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer

Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.